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Tomographic Angiography for Prediction
of Cardiac Events in Patients With
Suspected Coronary Artery Disease
Martin Hadamitzky, MD,* Barbara Freißmuth, MD,* Tanja Meyer, MD,*
Franziska Hein, MD,* Adnan Kastrati, MD,* Stefan Martinoff, MD,† Albert Schömig, MD,*
Jörg Hausleiter, MD*
Munich, Germany
O B J E C T I V E S We assessed the rate of cardiac events after detection or exclusion of obstructive
coronary artery disease (CAD) by coronary computed tomography angiography (CCTA).
B A C KG ROUND Several studies have demonstrated a high diagnostic accuracy of CCTA for
detection of obstructive CAD compared with invasive angiography, but data regarding the clinical
prognostic value of CCTA are limited.
METHOD S In all, 1,256 consecutive patients with suspected CAD undergoing 64-slice CCTA in our
institution between October 2004 and September 2006 were observed prospectively for the occurrence
of severe cardiac events (cardiac death, myocardial infarction, or unstable angina requiring hospitaliza-
tion: primary study end point) and all cardiac events (additionally including revascularization 90 days
after CCTA). The observed rate of all cardiac events was compared with the event rate predicted by the
Framingham risk score. Obstructive CAD was deﬁned as 50% diameter stenosis in any coronary artery.
R E S U L T S During a median follow-up of 18 months (interquartile range 14 to 25 months), the overall
rates of severe and all cardiac events were 0.6% and 1.8%, respectively. In 802 patients without
obstructive CAD, there were 4 cardiac events, of which 1 was severe, whereas in 348 patients with
obstructive CAD, there were 17 cardiac events, of which 5 were severe. The difference between the 2
groups was highly signiﬁcant both for severe events (odds ratio: 17.3, 95% conﬁdence interval: 3.6 to
82.5) and for all cardiac events (odds ratio: 16.1, 95% conﬁdence interval: 7.2 to 36.0; both p  0.001).
The rate of all cardiac events in patients without obstructive CAD was signiﬁcantly lower than predicted
by the Framingham risk score (p  0.01).
CONC L U S I O N S In patients with suspected CAD, CCTA has a signiﬁcant prognostic impact on the
prediction of cardiac events for the subsequent 18 months. The exclusion of obstructive CAD by CCTA
identiﬁes a patient population with an event risk lower than predicted by conventional risk
factors. (J Am Coll Cardiol Img 2009;2:404–11) © 2009 by the American College of Cardiology
Foundation
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405ardiovascular disease is the most common
cause of morbidity and mortality in Western
countries (1). The availability of effective
treatment options both by medical therapy
nd interventional as well as surgical procedures makes
t important to identify patients at risk and equally
mportant to identify patients not needing treatment.
oninvasive imaging techniques play an important
ole as a gatekeeper for invasive diagnostic and ther-
peutic procedures. A good prognostic accuracy and
n excellent negative predictive value for cardiac events
ave particularly been demonstrated for stress perfu-
ion imaging techniques such as nuclear myocardial
erfusion imaging and magnetic resonance stress per-
usion imaging (2,3).
During the last few years coronary computed
omography angiography (CCTA) has emerged as a
ew technique for noninvasive 3-dimensional visu-
lization of the coronary arteries. Although several
tudies showed good correlation between CCTA
nd invasive coronary angiography (4), concerns
emain regarding its prognostic value. The number
f studies investigating this topic is very limited
5–9). Therefore, the aim of this prospective obser-
ational study was to determine the predictive value
f CCTA for cardiovascular events in patients with
uspected coronary artery disease (CAD) and to
ompare the prognostic value of CCTA with the
re-test risk assessed by the Framingham risk score.
E T H O D S
tudy population. We prospectively enrolled all con-
ecutive patients undergoing CCTA on a 64-slice CT
canner (Siemens Somatom Sensation 64 Cardiac,
iemens, Forchheim, Germany) in our institution
rom October 1, 2004, to September 15, 2006. Writ-
en informed consent was obtained from all patients
efore the investigation. Patients were eligible for this
tudy if CAD was not previously known, but sus-
ected. Exclusion criteria comprised patients investi-
ated in an acute life-threatening condition and pa-
ients without stable sinus rhythm. A structured
nterview was performed before the investigation, and
nformation about age, height, and weight of the
atient, cardiac history, and current medication was
ollected. The following cardiac risk factors were
ecorded: 1) presence and degree of hypertension (for
inary analysis, a systolic blood pressure 140
m Hg was considered as abnormal regardless of
ntihypertensive therapy); 2) diabetes mellitus (de-
ned as fastening blood glucose level 7 mmol/l or
se of oral antidiabetic therapy or insulin); 3) smoking wdefined as current smoker or previous smoker within
he last year); and 4) a positive family history (defined
s presence of CAD in first-degree relatives55 years
f age if male and 65 years of age if female). In
ddition, laboratory tests for total cholesterol, low-
ensity lipoprotein and high-density lipoprotein frac-
ions, and triglycerides were performed. Finally, 2
rognostic scores were calculated: the Morise pre-test
core (10) and the Framingham risk score with the
stablished categorical model using low-density li-
oprotein cholesterol according to Wilson et al. (11).
he study design was approved by the local ethics
ommittee.
T procedure. The detailed CT scan protocol was
escribed elsewhere (12). In brief, to lower the heart
ate at the time of the CT study, up to 4 doses of 5 mg
etoprolol were administered intravenously to pa-
ients with a heart rate 60 beats/min. All patients
ith a systolic blood pressure of at least 100 mm Hg
eceived nitroglycerin 0.8 mg sublingually for coronary
asodilatation. Images for calcium scoring were ac-
uired by a noncontrast-enhanced scan and analyzed
ith a commercially available software pack-
ge (Siemens CalciumScore, Siemens, Er-
angen, Germany).
Contrast timing was tested by an initial
olus-timing scan using 20 cc of contrast
Iomeprol, Imeron 350, Bracco Altana
harma GmbH, Konstanz, Germany), io-
ine content 350 mg/cc, followed by a 50-cc
aline chaser. The contrast-enhanced scan
as obtained using 80 to 140 cc of contrast
ndividually adapted to the selected table feed and scan
ange at a rate of 4 to 5 cc/s followed by a 50-cc saline
haser. The scan was performed using a 32 0.6 mm
etector with oscillating beam, leading to an effective
esolution of 64  0.4 mm (13). For reduction of
adiation dose exposure, an electrocardiographically
ated tube current modulation was used in patients
ith stable sinus rhythm. Images were reconstructed
n mid-diastole with individually optimized position
f the reconstruction window. Additional image re-
onstructions were performed in end-systole if re-
uired. A dataset of axial slices, multiplanar reforma-
ions, and 3 perpendicular sets of thin-slab maximum
ntensity projections orientated along the heart axis
5-mm thickness, 1-mm increment) were recon-
tructed and investigated for the presence of obstruc-
ive CAD.
The coronary artery tree was segmented according
o the modified American Heart Association classifi-
ation (14). Each segment with a diameter 1.5 mm
A B B
A N D
CAD
CCTA
tomog
CI c
CTas evaluated visually by 2 experienced rR E V I A T I O N S
A C R O N YM S
coronary artery disease
 coronary computed
raphy angiography
onfidence intervaleaders
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4061 radiologist and 1 cardiologist) for the degree of
umen narrowings, and rated semiquantitatively by 4
roups:25%, 25% to 49%, 50% to 74%, and75%.
ifferences in the evaluation between the 2 readers
ere resolved by common consensus. If severe calci-
cation or other artifacts made a valid assessment
mpossible, the segment was classified as not evalu-
ble. The result of the CCTA was defined as nonob-
tructive if all evaluated segments had no lumen
arrowing50% and no artifacts leading to nondiag-
ostic image quality. The CCTA was defined as
bstructive if at least 1 segment had a lumen narrow-
ng 50% or if a relevant lumen narrowing could not
e ruled out because of severe artifacts. All patients
ith obstructive CAD by CCTA were advised to
ndergo invasive angiography.
ollow-up. Follow-up information was obtained ei-
her by clinical visits, telephone contact, or by detailed
uestionnaires sent by mail. All reported events were
erified by hospital records or direct contacts with the
ttending physician.
The following clinical events were recorded: 1)
ardiac death (including death without definitive
ause); 2) nonfatal myocardial infarction; 3) unstable
ngina pectoris requiring hospitalization; and 4) cor-
nary revascularization (either by bypass surgery or
ercutaneous coronary intervention). In addition, in-
ormation on noncardiac deaths was collected. Coro-
ary revascularizations occurring early after CCTA
ere obviously performed as a result of CCTA be-
ause all patients with obstructive CAD by CCTA
ere recommended to have invasive angiography and
ntervention as needed. Therefore, coronary revascu-
arization procedures performed earlier than 90 days
fter CCTA were excluded from further analysis. For
ollow-up analysis, all patients undergoing early revas-
ularization were censored at the time of the interven-
ion and therefore excluded from further analysis.
The primary end point of this study was the
omposite end point of “severe cardiac events” includ-
ng cardiac death, nonfatal myocardial infarction, and
nstable angina requiring hospitalization. The sec-
ndary end point was the combined end points of “all
ardiac events,” additionally including revasculariza-
ions later than 90 days after CCTA, representing the
vents defining CAD in the Framingham risk score
11).
The prognostic value of a noninvasive test like
CTA for CAD is strongly dependent on the pre-
est risk. To assess the additional value of the CCTA
oth for detecting and excluding obstructive CAD, we
ompared the observed rate of any cardiac events with
he event rate predicted by the Framingham risk score, fne of the best-evaluated scores for assessing the risk
or developing CAD (15,16). Because the Framing-
am risk score denotes the risk for developing symp-
omatic CAD within 10 years expressed in percent-
ges, the individual risk for a cardiac event within the
ollow-up period was calculated as Framingham risk
core/1,000 multiplied by the individual follow-up
eriod in years. For the patient group without obstruc-
ive CAD and the group with obstructive CAD, the
umulative predicted event rates were then calculated
s the sum of the individual risks and compared with
he observed event rate.
tatistical analysis. Categorical variables were ex-
ressed as frequencies and percentages; comparison
etween 2 groups was done by Fisher’s exact test.
ontinuous variables were expressed as median and
nterquartile range (first and third quartile) and com-
ared by Wilcoxon rank sum test. The occurrence of
ombined end points was analyzed by the Kaplan-
eier method, and odds ratios were calculated with
he log-rank test; for continuous variables, they were
alculated between values above and below median.
redictive values were denoted with their 95% confi-
ence interval (CI) calculated according to the mod-
fied Wald method (17). Statistical significance was
ccepted for p values 0.05. The software package R
version 2.6.1) was used for statistical analysis (18).
E S U L T S
tudy population and follow-up. In 1,667 patients,
CTA was performed during the study period. Of
hese, 411 had known CAD: 166 patients had a
istory of myocardial infarction, 217 patients had a
revious bypass surgery, 15 patients had a coronary
tent implanted, and 13 patients had otherwise known
AD. In addition, 5 patients had CCTA in acute
ife-threatening conditions (4 aortic dissections and 1
nfective endocarditis), and 56 patients had no stable
inus rhythm during the investigation. These 411
atients were excluded by protocol. From among the
emaining 1,195 patients, a clinical follow-up could be
stablished for 1,150 (96.2%). The median duration of
ollow-up was 540 days, with an interquartile range
rom 411 to 762 days and a total range from 303 to
,333 days. All evaluations are based on this patient
roup (Fig. 1).
atient characteristics. The median patient age was
0.2 years, with an interquartile range of 52.1 to 66.1
ears; 795 of the 1,150 (69%) patients were male. The
atient characteristics and coronary risk factor profile
irrors a study population of low to intermediate riskor CAD. The detailed patient characteristics and
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407ndications for CCTA are summarized in Table 1.
atients with arrhythmias had either exercise-induced
remature ventricular beats during stress testing or
hort runs of nonsustained ventricular tachycardias
uring Holter electrocardiographic monitoring or in-
ermittent atrial arrhythmias with increasing fre-
uency within the last year. “Other indications”
ainly consisted of exclusion of CAD before noncar-
iac surgery. All patients with coronary plaques or
tenoses, irrespective of the extent, were advised to
inimize their cardiovascular risk profile. Whenever
ndicated, we advised patients to stop smoking and to
igorously treat diabetes, and recommended acetylsa-
icylate, statins, and antihypertensive medication.
nvasive angiography and early revascularizations. As
result of CCTA, 348 (30%) patients were advised to
ndergo invasive coronary angiography, 129 (11%)
ecause of inconclusive findings and 219 (19%) be-
ause of obstructive CAD. Of these 348 patients, 215
62%) underwent invasive angiography within 90 days
fter CCTA, which was followed by revascularization
rocedures in 119 (34%) patients, 6 (2%) by coronary
rtery bypass graft and 113 (32%) by percutaneous
oronary intervention. All patients undergoing early
evascularization were censored at the time of the
ntervention for the event-free survival analysis. In 95
27%) patients, obstructive CAD was ruled out by
nvasive angiography, and 2 (1%) with obstructive
AD were treated medically; 132 (38%) patients did
ot undergo invasive angiography.
evere cardiac events. A total of 6 severe cardiac
vents occurred during follow-up, which compares
ith an overall event rate of 0.4% during the first year
fter CCTA. The severe cardiac events are summa-
ized in Table 2. Significantly more severe cardiac
vents were observed among patients with obstructive
AD (5 vs. 1 severe cardiac events, respectively, in
atients with obstructive vs. nonobstructive CAD;
 0.001 in the log-rank test) (Fig. 2), resulting in an
dds ratio for severe cardiac events of 17.3 (95% CI:
.6 to 82.5). For comparison, the odds ratios for the
resence of typical angina pectoris, the Morise pre-test
core, and the Framingham risk score were 4.5 (95%
I: 0.6 to 32.2), 1.7 (95% CI: 0.4 to 7.1), and 8.6
95% CI: 2.1 to 35.3), respectively; for the calcium
core, the odds ratio was 5.1 (95% CI: 0.7 to 34.9).
he event rate in the first year after CCTA calculates
o 0.1% (95% CI: 0.05 to 1.2) for patients with
onobstructive CAD and to 1.7% (95% CI: 0.6 to
.5) for patients with obstructive CAD.
ll cardiac events. During follow-up, significantly
ore late (90 days after CCTA) coronary revascu-arization procedures were performed in patients with 3bstructive CAD (15 vs. 3 revascularization proce-
ures in patients with obstructive vs. no obstructive
AD, respectively; p  0.001) (Table 2). With an
verall event rate during the first year after CCTA of
.1% for all cardiac events, this difference translates to
n odds ratio of 16.1 (95% CI: 7.2 to 36.0) (Fig. 3).
or comparison, the odds ratios for the presence of
ypical angina pectoris, the Morise pre-test score, and
he Framingham risk score were 2.0 (95% CI: 0.5 to
.3), 2.6 (95% CI: 1.1 to 6.1), and 3.3 (95% CI: 1.5 to
.6), respectively; for the calcium score, the odds ratio
as 7.7 (95% CI: 2.7 to 21.8). The event rate during
he first year after CCTA calculated to 0.3% (95% CI:
.1 to 0.8) in patients without obstructive CAD and
o 4.3% (95% CI: 2.3 to 7.9) in patients with obstruc-
ive CAD.
Looking at the stenosis grading, these events were
istributed as follows: 2 events among 498 patients
ith no stenosis 25%, 2 events among 304 patients
ith mild stenosis (25% to 49%), 11 events in 159
atients with a moderate stenosis (50% to 74%),
1,256 patients enrolled
1,195 patients eligible
1,150 patients included
802 patients without
obstructive CAD
348 patients with
obstructive CAD
severe cardiac events
    0 cardiac death
    0 nonfatal MI
    1 unstable angina
severe cardiac events
    0 cardiac death
    1 nonfatal MI
    4 unstable angina
45 patients lost on fol
Excluded:
    5 acute conditions
  56 unstable rhythm
Figure 1. Study Population and Severe Cardiac Events
Of the 1,256 patients evaluated, 4.8% were excluded because of ac
threatening conditions or unstable heart rhythm during examinatio
remaining patients, 96.2% could be contacted for follow-up. CAD 
nary artery disease; MI  myocardial infarction.low-up
ute life-
n. Of the
coro-events among 64 patients with high-grade stenoses
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40875%), and 3 events among 126 patients with
onevaluable segments. The pre-defined cutoff of
0% lumen narrowing proved to be most effective for
vent prediction as compared with levels of 25% and
5% of lumen narrowing. Although all 3 levels had a
ignificant prognostic value, the odds ratio of the 50%
acteristics and Indications
istics
No Obstructive CAD
(n  802)
Obstructive CAD
(n  348) p Value
58.6 [50.2–65.1] 62.9 [55.7–68.0] 0.001
525 (65) 269 (77) 0.001
2 25.4 [23.5–27.9] 26.4 [24.2–29.1] 0.001
221 (28) 120 (34) 0.02
258 (32) 139 (40) 0.01
) 47 (6) 46 (13) 0.001
n (%) 243 (30) 107 (31) 0.88
0.001
303 (38) 118 (34)
ris 30 (4) 38 (11)
ia, n (%) 61 (8) 34 (10) 0.22
dl
214 [189–241] 216 [189–250] 0.16
128 [104–150] 131 [107–154] 0.06
57 [48–70] 53 [44–66] 0.001
121 [85–174] 135 [97–195] 0.001
7.1 [4.2–12.1] 11.9 [7.1–17.8] 0.001
10 [8–12] 12 [10–14] 0.001
re 0 [0–32] 214 [53–627] 0.001
%) 0.11
296 (37) 139 (39)
emia 55 (7) 31 (9)
43 (5) 19 (5)
159 (20) 68 (20)
221 (28) 89 (26)
28 (3) 2 (1)
edian [interquartile range] or n (%).
isease; HDL  high-density lipoprotein; LDL  low-density lipoprotein.
ents and Combined End Points
No Obstructive CAD
(n  802)
Obstructive CAD
(n  348)
p
Value
Odds
Ratio
0 0
infarction 0 1 (0.3%) 0.13
1 (0.1%) 4 (1.1%) 0.03
n 3 (0.4%) 15 (4.4%) 0.001
ts 1 (0.1%) 5 (1.4%) 0.004 17.3
4 (0.5%) 17 (4.9%) 0.001 16.1
1 (0.1%) 6 (1.7%) 0.004
ist of cardiovascular death, nonfatal myocardial infarction, and unstable angina.t1.utoff of 16.1 was higher than those of the cutoffs of
5% and 75% (9.4 and 6.5, respectively).
omparison with conventional cardiovascular risk scor-
ng. The predicted risk according to the Framingham
isk score for patients without obstructive CAD cal-
ulated to 12 events, with a 95% CI ranging from 6 to
9 events. In this patient group, 4 events were ob-
erved. Accordingly, significantly fewer events than
redicted by the Framingham risk score occurred in
his group (p  0.01).
In patients with obstructive CAD, the number of
redicted events was 8, with a 95% CI ranging from
to 14 events. Here, the number of 17 observed
vents was significantly higher than predicted (p 
.003) (Fig. 4).
oncardiac deaths. One patient without obstructive
AD by CCTA died of pneumonia; in the patient
roup with obstructive CAD, 3 patients died of
alignancies, 2 of septicemia, and 1 of an embolic
erebral insult.
I S C U S S I O N
he key findings of this study are: 1) that patients
ith obstructive CAD by CCTA suffer significantly
ore frequently from severe as well as from all cardiac
vents than do patients without obstructive CAD; and
) that CCTA that excludes obstructive CAD iden-
ifies a population with a very low risk for severe
ardiac events (0.1%) and all cardiac events (0.3%) for
he following year.
omparison with recent publications. This study sig-
ificantly expands our current knowledge of the prog-
ostic value of CCTA. Min et al. (5) demonstrated a
ood correlation between CCTA results and all-cause
ortality in a study of comparable size. The main
imitation of this study is the missing distinction
etween cardiac and noncardiac deaths. Conse-
uently, this study does not answer the question to
hat extent this correlation is influenced by concom-
tant noncardiac morbidity or by a possible selection
ias, because CCTA is ordered more often for other-
ise ill patients. Our observation that noncardiac
eaths are far more common than cardiac deaths
uggests that this confounding might be substantial.
onsequently, the results of the Min et al. study (5)
lone cannot be used as a base for decisions on further
ardiac treatment.
Punziute et al. (6) and Gaemperli et al. (8) could
emonstrate a significant prognostic value for cardiac
vents and a very good prognosis for patients without
bstructive CAD. Limitations of both studies areTable 1. Patient Char
Clinical Character
Age, yrs
Male, n (%)
Body mass index, kg/m
Hypertension, n (%)
Smoking, n (%)
Diabetes mellitus, n (%
Family history of CAD,
Chest pain, n (%)
Atypical chest pain
Typical angina pecto
Positive test for ischem
Laboratory values, mg/
Total cholesterol
LDL cholesterol
HDL cholesterol
Triglycerides
Framingham risk score
Morise pre-test score
Calcium (Agatston) sco
Leading indication, n (
Chest pain
Positive test for isch
Dyspnea
Arrhythmias
Elevated risk proﬁle
Other indications
Values are expressed as mTable 2. Follow-Up Ev
Cardiac events
Cardiac death
Nonfatal myocardial
Unstable angina
Late revascularizatio
Combined end points
Severe cardiac even
All cardiac events
Noncardiac death
Severe cardiac events consheir rather small study populations of 100 and 220
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409atients, respectively. Furthermore, patients with sus-
ected and already known CAD were included in
oth studies, resulting in an inhomogeneous patient
opulation. In addition, both studies included early
evascularizations, which are predominantly driven by
he CCTA itself, into their end points. Early revas-
ularization procedures reflect the result of CCTA,
ut not long-term effects. Thus, we excluded these in
he current analysis.
Gilard et al. (7) showed a low incidence of cardiac
vents after normal CCTA in patients with suspected
AD in a small study with 141 patients. The event
ate of 0.6% per year for severe cardiac events was
lightly higher than our event rates. No follow-up for
atients with obstructive CAD for comparison was
erformed. Danciu et al. (9) investigated a very se-
ected population of 421 patients with intermediate
isk after scintigraphic myocardial perfusion stress
maging and showed a low event rate of 0.3% for
atients assigned to medical treatment compared with
9% for the 28 patients referred to invasive angiogra-
hy and not undergoing immediate revascularization.
rognostic value of CCTA. One important goal of
oninvasive imaging techniques for evaluation of car-
iovascular risk is the ability to further differentiate
igh-risk patients from low-risk patients after conven-
ional risk scoring. The current study demonstrates
his ability for severe cardiac events and for all cardiac
vents. The significant difference in all cardiac events
uggests that CCTA is not only capable of excluding
bstructive CAD but also of assessing the risk of
rogression of CAD. Some studies showed that a
onsiderable fraction of acute myocardial infarctions
re caused by lesions classified as nonobstructive in
revious angiograms (19,20). Nevertheless, in the
urrent study, an extent of 50% lumen narrowing in
isual assessment proved as an effective cutoff value for
he prediction of cardiac events. A further evaluation
f nonobstructive lesions regarding number, extent, or
laque composition was not performed because of the
mall number of events in the patient group without
bstructive CAD.
Another important goal is the precise definition of
low-risk patient group. The established modalities
re nuclear stress myocardial perfusion imaging and,
ore recently, magnetic resonance stress imaging,
oth consistently showing event rates for severe car-
iac events below 1% per year in multiple studies
3,21,22). With a rate of 0.3% per year for all cardiac
vents and 0.1% per year for severe cardiac events in
his large patient group with suspected CAD, the
urrent study is an important step for establishing
CTA as an equivalent method. Obviously, theuoted weakness of the CCTA of only focusing on
oronary anatomy and lumen narrowing and not
ssessing the extent of the resulting ischemia does not
eem to play an important role in cardiac prognosis, at
east in the first year, but certainly further evaluation of
his topic is needed.
The negative predictive value of CCTA, like any
ther investigation, is strongly dependent on the
re-test risk. Because a good negative predictive value
n a low-risk patient group can solely be caused by the
ow overall pre-test risk, we compared the observed
vent rate with the pre-test risk. The latter was
stimated by the Framingham risk score, because it is
idely accepted and well tested (15,16). The observed
vent rate among patients without obstructive CAD
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Figure 2. Kaplan-Meier Curve for Severe Cardiac Events
Severe cardiac events are deﬁned as cardiac death, nonfatal myoca
infarction, or unstable angina requiring hospitalization. The event ra
patients without obstructive coronary artery disease (CAD) (brown
0.12%; for patients with obstructive CAD (orange line), it was 1.5%
ratio: 17.3, 95% CI: 3.6 to 82.5). No severe cardiac event occurred af
nary revascularization.
Figure 3. Kaplan-Meier Curve for All Cardiac Events
All cardiac events are deﬁned as cardiac death, nonfatal myocardial
tion, unstable angina requiring hospitalization, or coronary revascul
later than 90 days after coronary computed tomography angiograp
event rate for patients without obstructive coronary artery disease
(orange line) was 0.25%; for patients with obstructive CAD (browns 
rdial
te for
line) was
(odds
ter coro-infarc-
arization
hy. The
(CAD)
line), itwas 4.3% (odds ratio: 16.1, 95% CI: 7.2 to 36.0).
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410as significantly lower than predicted, whereas signif-
cantly more events occurred than predicted among
atients with obstructive CAD. Thus, the current
tudy demonstrates that CCTA appears to be very
aluable in a further risk differentiation in addition to
ramingham risk score.
Looking at the patients with obstructive CAD,
early one-third of the patients advised to have inva-
ive angiography did not undergo cardiac catheteriza-
ion. Obviously, a significant number of patients were
orried enough about the threat of cardiac disease to
ndergo a CT scan but were not worried enough to
ndergo invasive angiography, if necessary. Consider-
ng that all cardiac events occurred in patients with
bstructive CAD by CCTA but not undergoing
ecommended invasive angiography emphasizes the
mportance of thorough patient information on the
onsequences of both a normal and an abnormal test
esult.
tudy limitations. The overall event rates of 0.6% for
evere cardiac events and 1.8% for all cardiac events
re rather low. This finding precludes a valid
ultivariate analysis for comparison of CCTA with
ther risk predictors. In addition, the results of this
tudy might not be valid for a high-risk patient
opulation. The low event rate is, at least in part, a
esult of the high number of asymptomatic patients
n the study population. Published data regarding
he value of CCTA in this patient group are sparse
t the moment.
The comparison of follow-up events between the
patient groups is influenced by further diagnostic
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Figure 4. Number of All Cardiac Events, Predicted by Framingh
On the left-hand side of each diagram, the number of events predi
interval. On the right-hand side, the actually observed number of e
ease (CAD), the observed event rate was signiﬁcantly lower than pr
event rate was signiﬁcantly higher than predicted.nd therapeutic procedures initiated by the investi- eation, first of all by subsequent coronary revascu-
arizations. Although such effects are inevitable in a
tudy observing routine clinical treatment pathways,
ne has to keep in mind that the result of the
omparison probably is substantially influenced by
ow abnormal or equivocal results are handled.
evertheless, the difference in the event rates was
ot influenced by complications of revasculariza-
ion, because patients were censored for the end
oint of all cardiac events after the first revascular-
zation (both early and late), and all severe cardiac
vents in the group with obstructive CAD occurred
n patients who did not have recommended invasive
ngiography.
O N C L U S I O N S
CTA has emerged as a method for noninvasive
ssessment of CAD with an excellent negative
redictive value, when compared with invasive cor-
nary angiography. On top of this, our study clearly
emonstrates the capability of CCTA for the pre-
iction of cardiac events in patients with suspected
AD. Significantly more severe and all cardiac
vents occurred in patients with obstructive CAD
y CCTA than in patients without obstructive
AD. The exclusion of obstructive CAD by
CTA is associated with a very high negative
redictive value for cardiac events in the following
8 months, and the observed event rate is signifi-
antly lower than predicted by the Framingham risk
core. These findings add substantial evidence to
predicted observed
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by Framingham risk score is given with the 95% conﬁdence
s is given. For patients without obstructive coronary artery dis-
ted, whereas for patients with obstructive CAD, the observedam
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edicstablishing CCTA as a routine modality for as-
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411essing the risk for cardiac events of patients with
uspected CAD.
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